Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma.

Mazloom AR, Džakula Ž, Oeth P, Wang H, Jensen T, Tynan J, McCullough R, Saldivar JS, Ehrich M, van den Boom D, Bombard AT, Maeder M, McLennan G, Meschino W, Palomaki GE, Canick JA, Deciu C.

Prenat Diagn. 2013 Jun;33(6):591-7. doi: 10.1002/pd.4127.

PMID:
23592550
[PubMed - indexed for MEDLINE]
2.

The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.

Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE.

Prenat Diagn. 2013 Jul;33(7):667-74. doi: 10.1002/pd.4126. Epub 2013 May 31.

PMID:
23592541
[PubMed - indexed for MEDLINE]
3.

High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma.

Jensen TJ, Zwiefelhofer T, Tim RC, Džakula Ž, Kim SK, Mazloom AR, Zhu Z, Tynan J, Lu T, McLennan G, Palomaki GE, Canick JA, Oeth P, Deciu C, van den Boom D, Ehrich M.

PLoS One. 2013;8(3):e57381. doi: 10.1371/journal.pone.0057381. Epub 2013 Mar 6.

PMID:
23483908
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.

Lambert-Messerlian GM, Palomaki GE, Eklund EE, Kloza EM, Neveux LM, Phipps MG, Canick JA.

J Med Screen. 2012 Dec;19(4):164-70. doi: 10.1258/jms.2012.012086. Epub 2012 Dec 31.

PMID:
23277614
[PubMed - indexed for MEDLINE]
5.

Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy.

Haddow JE, Craig WY, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, D'Alton ME; First And Second Trimester Risk Of Aneuploidy Faster Research Consortium.

Thyroid. 2013 Feb;23(2):225-30. doi: 10.1089/thy.2012.0440.

PMID:
23136959
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Maternal plasma DNA: a major step forward in prenatal testing.

Canick JA, Palomaki GE.

J Med Screen. 2012 Jun;19(2):57-9. doi: 10.1258/jms.2012.012059. No abstract available.

PMID:
22753874
[PubMed - indexed for MEDLINE]
7.

DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.

Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE.

Prenat Diagn. 2012 Aug;32(8):730-4. doi: 10.1002/pd.3892. Epub 2012 May 14.

PMID:
22585317
[PubMed - indexed for MEDLINE]
8.

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA.

Genet Med. 2012 Mar;14(3):296-305. doi: 10.1038/gim.2011.73. Epub 2012 Feb 2.

PMID:
22281937
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA.

Genet Med. 2011 Nov;13(11):913-20. doi: 10.1097/GIM.0b013e3182368a0e.

PMID:
22005709
[PubMed - indexed for MEDLINE]
10.

The relationship between PTH and 25-hydroxy vitamin D early in pregnancy.

Haddow JE, Neveux LM, Palomaki GE, Lambert-Messerlian G, Canick JA, Grenache DG, Lu J.

Clin Endocrinol (Oxf). 2011 Sep;75(3):309-14. doi: 10.1111/j.1365-2265.2011.04066.x.

PMID:
21521334
[PubMed - indexed for MEDLINE]
11.

Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.

Zhang J, Lambert-Messerlian G, Palomaki GE, Canick JA.

Prenat Diagn. 2011 Jun;31(6):583-8. doi: 10.1002/pd.2755. Epub 2011 Apr 11.

PMID:
21480302
[PubMed - indexed for MEDLINE]
12.

Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption.

Haddow JE, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D'Alton ME; First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium.

Obstet Gynecol. 2011 Feb;117(2 Pt 1):287-92. doi: 10.1097/AOG.0b013e31820513d9.

PMID:
21252741
[PubMed - in process]
13.

Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetes.

Sprawka N, Lambert-Messerlian G, Palomaki GE, Eklund EE, Canick JA.

Prenat Diagn. 2011 Mar;31(3):282-5. doi: 10.1002/pd.2679. Epub 2011 Jan 4.

PMID:
21207406
[PubMed - indexed for MEDLINE]
14.

Four years' experience with an interlaboratory comparison program involving first-trimester markers of Down syndrome.

Palomaki GE, Knight GJ, Lambert-Messerlian G, Canick JA, Haddow JE.

Arch Pathol Lab Med. 2010 Nov;134(11):1685-91. doi: 10.1043/2009-0670-OAR.1.

PMID:
21043823
[PubMed - indexed for MEDLINE]
15.

Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access(®) platform: suitability for use in first trimester Down's syndrome screening.

Lambert-Messerlian G, Palomaki GE, Canick JA.

J Med Screen. 2010;17(3):109-13. doi: 10.1258/jms.2010.010041.

PMID:
20956719
[PubMed - indexed for MEDLINE]
16.

Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery.

Haddow JE, Cleary-Goldman J, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D'Alton ME; First- and Second-Trimester Risk of Aneuploidy (FaSTER) Research Consortium.

Obstet Gynecol. 2010 Jul;116(1):58-62. doi: 10.1097/AOG.0b013e3181e10b30.

PMID:
20567168
[PubMed - indexed for MEDLINE]
17.

Early onset preeclampsia and second trimester serum markers.

Lambert-Messerlian GM, Palomaki GE, Neveux LM, Chien E, Friedman A, Rosene-Montella K, Hayes M, Canick JA.

Prenat Diagn. 2009 Dec;29(12):1109-17. doi: 10.1002/pd.2387.

PMID:
19842088
[PubMed - indexed for MEDLINE]
18.

Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements.

Palomaki GE, Lee JE, Canick JA, McDowell GA, Donnenfeld AE; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2009 Sep;11(9):669-81. doi: 10.1097/GIM.0b013e3181ad5246. Erratum in: Genet Med.2009 Dec;11(12):873.

PMID:
19690509
[PubMed - indexed for MEDLINE]
19.

Adjustment of serum markers in first trimester screening.

Lambert-Messerlian G, Palomaki GE, Canick JA.

J Med Screen. 2009;16(2):102-3. doi: 10.1258/jms.2009.009028.

PMID:
19564524
[PubMed - indexed for MEDLINE]
20.

Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.

D'Alton ME, Cleary-Goldman J, Lambert-Messerlian G, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes K, Canick JA, Malone FD.

Ultrasound Obstet Gynecol. 2009 Feb;33(2):142-6. doi: 10.1002/uog.6265.

PMID:
19173241
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk